Min SS - Search Results

1

Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction.

Lim ML, Min SS, Eron JJ, Bertz RJ, Robinson M, Gaedigk A, Kashuba AD. Lim ML, et al. Among authors: min ss. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1034-40. doi: 10.1097/00126334-200408150-00006. J Acquir Immune Defic Syndr. 2004. PMID: 15247556 Clinical Trial.

2

Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women.

Min SS, Corbett AH, Rezk N, Cu-Uvin S, Fiscus SA, Petch L, Cohen MS, Kashuba AD. Min SS, et al. J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1577-80. doi: 10.1097/00126334-200412150-00008. J Acquir Immune Defic Syndr. 2004. PMID: 15577412

3

Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir.

Tappouni HL, Rublein JC, Donovan BJ, Hollowell SB, Tien HC, Min SS, Theodore D, Rezk NL, Smith PC, Tallman MN, Raasch RH, Kashuba AD. Tappouni HL, et al. Among authors: min ss. Am J Health Syst Pharm. 2008 Mar 1;65(5):422-8. doi: 10.2146/ajhp070226. Am J Health Syst Pharm. 2008. PMID: 18281734 Free PMC article. Clinical Trial.

4

Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.

Eron JJ, Clotet B, Durant J, Katlama C, Kumar P, Lazzarin A, Poizot-Martin I, Richmond G, Soriano V, Ait-Khaled M, Fujiwara T, Huang J, Min S, Vavro C, Yeo J; VIKING Study Group. Eron JJ, et al. J Infect Dis. 2013 Mar 1;207(5):740-8. doi: 10.1093/infdis/jis750. Epub 2012 Dec 7. J Infect Dis. 2013. PMID: 23225901 Free PMC article. Clinical Trial.

5

Coadministration of esomeprazole with fosamprenavir has no impact on steady-state plasma amprenavir pharmacokinetics.

Shelton MJ, Ford SL, Borland J, Lou Y, Wire MB, Min SS, Xue ZG, Yuen G. Shelton MJ, et al. Among authors: min ss. J Acquir Immune Defic Syndr. 2006 May;42(1):61-7. doi: 10.1097/01.qai.0000219770.97303.43. J Acquir Immune Defic Syndr. 2006. PMID: 16639341

6

Lack of interaction between the HIV integrase inhibitor S/GSK1349572 and tenofovir in healthy subjects.

Song I, Min SS, Borland J, Lou Y, Chen S, Ishibashi T, Wajima T, Piscitelli SC. Song I, et al. Among authors: min ss. J Acquir Immune Defic Syndr. 2010 Nov;55(3):365-7. doi: 10.1097/QAI.0b013e3181e67909. J Acquir Immune Defic Syndr. 2010. PMID: 20585260

7

Effects of etravirine alone and with ritonavir-boosted protease inhibitors on the pharmacokinetics of dolutegravir.

Song I, Borland J, Min S, Lou Y, Chen S, Patel P, Wajima T, Piscitelli SC. Song I, et al. Antimicrob Agents Chemother. 2011 Jul;55(7):3517-21. doi: 10.1128/AAC.00073-11. Epub 2011 May 9. Antimicrob Agents Chemother. 2011. PMID: 21555764 Free PMC article. Clinical Trial.

8

The effect of lopinavir/ritonavir and darunavir/ritonavir on the HIV integrase inhibitor S/GSK1349572 in healthy participants.

Song I, Min SS, Borland J, Lou Y, Chen S, Patel P, Ishibashi T, Piscitelli SC. Song I, et al. Among authors: min ss. J Clin Pharmacol. 2011 Feb;51(2):237-42. doi: 10.1177/0091270010371113. Epub 2010 May 20. J Clin Pharmacol. 2011. PMID: 20489027 Clinical Trial.

9

Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study.

Castagna A, Maggiolo F, Penco G, Wright D, Mills A, Grossberg R, Molina JM, Chas J, Durant J, Moreno S, Doroana M, Ait-Khaled M, Huang J, Min S, Song I, Vavro C, Nichols G, Yeo JM; VIKING-3 Study Group. Castagna A, et al. J Infect Dis. 2014 Aug 1;210(3):354-62. doi: 10.1093/infdis/jiu051. Epub 2014 Jan 19. J Infect Dis. 2014. PMID: 24446523 Free PMC article. Clinical Trial.

10

Pharmacokinetic and safety evaluation of high-dose combinations of fosamprenavir and ritonavir.

Shelton MJ, Wire MB, Lou Y, Adamkiewicz B, Min SS. Shelton MJ, et al. Among authors: min ss. Antimicrob Agents Chemother. 2006 Mar;50(3):928-34. doi: 10.1128/AAC.50.3.928-934.2006. Antimicrob Agents Chemother. 2006. PMID: 16495253 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page